Why Take This Course
Significance of the Problem
Goals and Objectives
Goals and Objectives
How to use this course
about Danya Institute
about CHHATT
authors
acknowledgements
accreditation
Before You Start Course Modules Resources My DLC Profile return to DLC
Before You Start  >>  Why Should I Take This Course?   

Why Should I Take This Course?

  • Hepatitis C is the most common chronic blood-borne infection in the United States. Approximately 4 million Americans have been infected with the hepatitis C virus (HCV).


  • Epidemiologic studies demonstrate that HCV is now endemic among injection drug users, resulting from such behaviors as sharing syringes and other drug paraphernalia.


  • Over the past decade, injection drug use has become the major transmission mode of HCV in the United States, accounting for at least 60 percent of transmitted cases.


  • Because of the serious medical consequence that can result from hepatitis C infection, programs serving substance abusers need to be able to inform their clients about HCV infection and counsel them on appropriate responses to the risk of HCV.


  • Addiction treatment providers can enhance their treatment services by becoming informed about hepatitis C and its effects, modes of transmission and risk factors, testing and treatment options, and prevention messages.
     
1of10next

Developed by the Danya Institute and Danya International, Inc., with funding from the
Center for Substance Abuse Treatment.

Contact Us
Last updated: October 11, 2002.